United States

PureTech Health PLC (PTCHF.PK)

PTCHF.PK on OTC Markets Group - US Other OTC and Grey Market

19 Sep 2017
Change (% chg)

$0.03 (+1.71%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets. This segment... (more)


Beta: --
Market Cap(Mil.): £322.28
Shares Outstanding(Mil.): 237.43
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 80.15 16.18
EPS (TTM): -- -- --
ROI: -- 3.01 14.60
ROE: -- 4.76 13.87

BRIEF-PureTech initiates phase 2b inhibitors study in respiratory tract infections

* Announces initiation of phase 2b mtorc1 inhibitors study in elderly patients at increased risk of respiratory tract infections

May 09 2017

BRIEF-PureTech Health launches new immuno-oncology programme

* Advances new programme targeting immunosuppressive gamma delta t cells and related mechanisms

Apr 11 2017

BRIEF-PureTech Health's Akili announces pilot study results

* Results from project EVO pilot study showed improved cognitive control in children with sensory processing dysfunction, attentional deficits Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Apr 06 2017

Earnings vs. Estimates